Ana Martínez-Cañavate

Ana Martínez-Cañavate

Auto-generated profile, based on publicly available information

Ana Martínez-Cañavate

Hospital Universitario Virgen de las Nieves Granada Spain

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2024 in Pediatric Allergy and Immunology
Verified
Journal Article
Closed access
MCM. Cabrera
M. Cabrera
DRD. Ryan
D. Ryan
MEM. Erlewyn‐Lajeunesse
M. Erlewyn‐Lajeunesse
MLM. Levin
M. Levin
AMA. Martínez‐Cañavate
A. Martínez‐Cañavate
LRL. Reali
L. Reali

13 January 2023 in Pediatric Allergy and Immunology
Verified
Journal Article
Closed access
MCMartha Cabrera
Martha Cabrera
DRDermot Ryan
Dermot Ryan
MEMichel Erlewyn‐Lajeunesse
Michel Erlewyn‐Lajeunesse
MLMichael Eliad Levin
Michael Eliad Levin
AMAna Martínez‐Cañavate
Ana Martínez‐Cañavate
LRLaura Reali
Laura Reali

30 July 2019 in Revista Alergia México
Verified
Journal Article
Open access
PDF file
AAAna Pérez Aragón
Ana Pérez Aragón
MDManuel Díaz-Molina
Manuel Díaz-Molina
MRMaría Teresa Romero-Paniagua
María Teresa Romero-Paniagua
AMAna Martínez-Cañavate
Ana Martínez-Cañavate
Corticosteroids are drugs widely used in medical practice due to their potent anti-inflammatory and immunomodulatory effect. Although most of the adverse reactions are well known, allergic reactions are uncommon. Hydrocortisone and methylprednisolone are the most commonly implicated drugs. An estimated 0.3% incidence of allergic reactions, some of them severe, has been estimated, so the possibility of their occurrence should be considered when these medications are used.

15 April 2024
Verified
Preprint
Open access
PDF file
MCMartha Cabrera
Martha Cabrera
DRD Ryan
D Ryan
MEMichel Erlewyn-Lajeunesse
Michel Erlewyn-Lajeunesse
MLMichael Levin
Michael Levin
AMAna Martínez-Cañavate
Ana Martínez-Cañavate
RLReali L
Reali L
Background Paediatricians are often the first point of contact for children in Primary Care (PC), but still perceive gaps in their allergy knowledge. We investigated self-perceived knowledge gaps and educational needs in paediatricians across healthcare systems in Europe so that future educational initiatives may better support the delivery of allergy services in PC. Methods A multinational survey was circulated to paediatricians who care for children and adolescents with allergy problems in PC by the EAACI Allergy Educational Needs in Primary Care Paediatricians Task Force during February to March 2023. A 5-point Likert scale was used to assess level of agreement with questionnaire statements. 30 surveys per country was the cut-off for inclusion and statistical analysis. Results 1,991 respondents were obtained from 56 countries across Europe and 210 responses were from countries with a cut-off below 30 participants per country. Primary care paediatricians (PCPs) comprised 74.4% of the respondents. The majority (65.3%) were contracted to state or district health services. 61.7% had awareness of guidelines for onward allergy referral in their countries but only 22.3% were aware of the EAACI competencies document for allied health professionals for allergy. Total sample respondents versus PCP’s showed 52% and 47% of them have access to allergy investigations in their PC facility (mainly specific IgE and skin prick tests); 67.6% and 58.9% have access to immunotherapy, respectively. The main barrier for referral to a specialist was consideration that the patient’s condition could be diagnosed and treated in this PC facility, (57.8% and 63.6% respectively). The main reasons for referral was the need for hospital assessment, and partial response to first line treatment (55.4% and 59.2%, 47% and 50.7%, respectively). Learning and assessment methods preference was fairly equally divided between: Traditional methods (45.7% and 50.1% respectively) and e-Learning 45.5% and 44.9%, respectively. Generalist Physicians (GP’s) have the poorest access to allergy investigations (32.7%, p=0.000). The majority of the total sample (91.9%) assess patients with allergic pathology. 868 (43.6%) and 1,117 (46.1%), received allergy training as undergraduates and postgraduates respectively [these proportions in PCPs were higher (45% and 59%), respectively]. PCPs with special interest in allergology experienced greater exposure to allergy teaching as postgraduates. GP’s received the largest amount of allergy teaching as undergraduate. Identifying allergic disease based on clinical presentation, respondents felt most confident in the management of eczema/atopic dermatitis (87.4%) and rhinitis/asthma (86.2%), and least confident in allergen immunotherapy (36.9%) and latex allergy (30.8%). Conclusion This study exploring the confidence of PCP’s to diagnose, manage and refer patients with allergy, demonstrated knowledge gaps and educational needs for allergy clinical practice. It detects areas in need of urgent improvement especially in latex and allergen immunotherapy. It is important to ensure dissemination of allergy guidelines and supporting EAACI documents since the majority of PCPs lack awareness of them. This survey has enabled us to identify what the educational priorities of PCPs are and how they would like to have them met.

16 September 2026 in Pediatric Allergy and Immunology
Verified
Journal Article
Open access
MLMontserrat Alvaro Lozano
Montserrat Alvaro Lozano
AMAna María Martínez‐Cañavate
Ana María Martínez‐Cañavate
FCFrancisco Carballada
Francisco Carballada
MMMaría Mesa‐Del‐Castillo
María Mesa‐Del‐Castillo
JAJosé Ángel Porto Arceo
José Ángel Porto Arceo
FLFernando Pineda de la Losa
Fernando Pineda de la Losa
Background: Allergic rhinitis and asthma in childhood arise from dynamic interactions between genetic predisposition and the exposome. However, how environmental heterogeneity shapes molecular IgE sensitization profiles during early life remains insufficiently characterized. Methods: We conducted a prospective, observational, multicentre, cross‐sectional study including 354 children (0–15 years) with allergic rhinitis and/or asthma recruited across eight Spanish cities contrasting regional climatic contexts. All patients were skin prick test‐positive to at least one aeroallergen and underwent multiplex component‐resolved diagnostics using the ALEX platform. Sensitization patterns were analyzed, and unsupervised approaches were applied to identify molecular signatures. Results: Molecular IgE profiling revealed a structured sensitization landscape, with 97.5% of children exhibiting reactivity to at least one allergen. A dominant mite‐related pattern and partially distinct pollen‐ and epithelial‐related patterns were observed. PCA identified composite molecular sensitization gradients and descriptive differences in participant distributions across recruitment centres, although substantial overlap was observed between centres. Age‐stratified analyses identified a non‐linear trajectory of sensitization, characterized by early molecular priming in high‐exposure environments, followed by a marked expansion of IgE levels and allergen sensitization during school age. Rhinitis severity was strongly associated with a denser mite sensitization network. In contrast, asthma severity was driven not by mite sensitization alone but by a complex pollen‐related polysensitization. Conclusion: Pediatric IgE sensitization is structured into molecular patterns associated with geography and age, consistent with a role for environmental context in early allergic trajectories. image